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Abstract
Background: Hereditary inclusion body myopathy (HIBM) is a rare neuromuscular disorder caused by mutations in GNE, the
key enzyme in the biosynthetic pathway of sialic acid. While the mechanism leading from GNE mutations to the HIBM
phenotype is not yet understood, we searched for proteins potentially interacting with GNE, which could give some insights
about novel putative biological functions of GNE in muscle.
Methodology/Principal Findings: We used a Surface Plasmon Resonance (SPR)-Biosensor based assay to search for
potential GNE interactors in anion exchanged fractions of human skeletal muscle primary culture cell lysate. Analysis of the
positive fractions by in vitro binding assay revealed a-actinin 1 as a potential interactor of GNE. The direct interaction of the
two proteins was assessed in vitro by SPR-Biosensor based kinetics analysis and in a cellular environment by a co-
immunoprecipitation assay in GNE overexpressing 293T cells. Furthermore, immunohistochemistry on stretched mouse
muscle suggest that both GNE and a-actinin 1 localize to an overlapping but not identical region of the myofibrillar
apparatus centered on the Z line.
Conclusions/Significance: The interaction of GNE with a-actinin 1 might point to its involvement in a-actinin mediated
processes. In addition these studies illustrate for the first time the expression of the non-muscle form of a-actinin, a-actinin
1, in mature skeletal muscle tissue, opening novel avenues for its specific function in the sarcomere. Although no significant
difference could be detected in the binding kinetics of a-actinin 1 with either wild type or mutant GNE in our SPR biosensor
based analysis, further investigation is needed to determine whether and how the interaction of GNE with a-actinin 1 in
skeletal muscle is relevant to the putative muscle-specific function of a-actinin 1, and to the muscle-restricted pathology of
HIBM.
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Introduction
Hereditary inclusion body myopathy (HIBM) is a unique
neuromuscular disorder characterized by adult-onset, slowly
progressive distal and proximal muscle weakness, presenting with
an unusual feature, the sparing of the quadriceps. HIBM fibers
have typical muscle pathology, including cytoplasmic rimmed
vacuoles and cytoplasmic or nuclear filamentous inclusions
composed of tubular filaments [1]. The disease is particularly
common in the Jewish Persian community (with a prevalence of 1
in 1 500), and has been described also worldwide in non-Jewish
families, particularly in Japan [2]. The GNE gene, encoding the bi-
functional enzyme UDP-N-acetylglucosamine 2-epimerase/N-
acetylmannosamine kinase (UDP-GlcNAc 2-epimerase/ManNAc
kinase), is mutated in all HIBM patients studied to date. A single
homozygous missense mutation, M712T, located at exon 12 of the
gene, within its kinase domain, was identified in all Persian and
other Middle Eastern Jewish and non-Jewish HIBM patients [3].
Other missense mutations in GNE have been identified in HIBM
patients worldwide [4–7]. GNE catalyzes two sequential steps in
the biosynthetic pathway of sialic acid [8], the most abundant
terminal monosaccharide on glycoconjugates of eukaryotic cells
[9]. The process by which mutations in this enzyme lead to the
disease is not yet understood, and the issue of hyposialylation in
HIBM muscles is still not resolved [10–13]. To find out whether
GNE has other yet unknown biological functions in muscle tissue,
which could be involved in the pathogenesis of HIBM, we tried to
identify potential partners interacting with GNE. Such interactions
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besides its known function in sialylation, and as such, could be
evaluated for potential involvement in HIBM pathophysiology. We
used an optical SPR-biosensor (Surface Plasmon Resonance) system,
BIAcore [14,15], to test GNE’s interactions. This analysis, followed
by in vitro binding assay and mass spectrometry, led to the
identification of two potential GNE binding proteins. Using kinetics
BIAcore analysis, co-IP and confocal microscopy, we show that one
of them, a-actinin 1, interacts with GNE both in vitro and in vivo.
Materials and Methods
Unless otherwise stated, all chemicals were obtained from
SIGMA (St. Louis, MO, USA). Cell culture media were obtained
from Biological Industries (Beit Haemek, Israel).
GNE proteins expression and purification
GNE cDNAs were generated from total RNA isolated from
lymphoblastoid cell lines derived from a healthy individual and
from an HIBM patient carrying the M712T mutation in GNE,a s
described [10]. The cDNA sequences were cloned into pFAST-
BACAHTa expression vectors, expressed in insect cells and
purified as described [10]. Freshly purified His-tagged wild type
(WT) and mutant GNE proteins were bound to the BIAcore chip
or used for in vitro binding assay.
Cell lysis
A previously established and well characterized skeletal muscle
primary cell culture [16], derived from deltoid biopsy of a 46 years
old healthy male donor, was used in this study. Cells at passage 8
were grown till sub-confluency in 75 cm
2 flasks, treated with
trypsin, collected and washed twice in ice-cold PBS. Cell pellets
were suspended in hypotonic ice-cold lysis buffer (100 ml/10
6 cells;
10 mM NaPi buffer pH 8, 0.1 mM EDTA, 0.1 mM DTT, 1 mM
PMSF, 17 mg/ml Aprotinin, 10 mg/ml leupeptin, 1 mM Vana-
date, 20 Mm b-Glycerophosphate), incubated on ice for 309, lysed
by 20 strokes through a 26 gauge needle, and centrifuged
(14,000 rpm for 309 at 4uC). Protein concentration was deter-
mined using Bradford Reagent (SIGMA). Fresh protein lysate was
used on the same day for anion exchanged chromatography.
Anion exchanged chromatography
Total protein lysate (15 mg) was diluted with buffer A (20 mM
KPO4 pH 8.0) to 4.5 ml. Anion exchange chromatography was
performed on an AKTA Explorer with a 1 ml Resource 30Q
column (GE Healthcare–Amersham Pharmacia, Uppsala, Sweden).
Samplewas loaded on a column, washed with 25 mlbuffer A, eluted
in20 mlgradient 0–100%of bufferB (20 mMKPO4 pH 8.0+ 1M
NaCl) and collected in fractions of 1.2 ml. After elution, fractions
with more than 0.2 M NaCl were dialyzed against 0.1 M NaCl
buffer. Freshly prepared fractions were used for BIAcore analyses.
BIAcore analysis
All experiments were carried out using BIAcore 3000 (BIAcore,
Uppsala, Sweden) and sensor chip CM5 (BIAcore), at 25uC. For
activating the chip, EDC/NHS amine coupling protocol was used
according to BIAcore protocol (www.biacore.com). WT and mutant
GNE proteins (100 mg/ml), in 10 mM acetate pH 6, were
immobilized to give about 3000 RU in the analyte identification
experiments and up to 600 RU in the kinetics experiments. The
running buffer used was Na-phosphate buffer (10 mM NaPi pH 7.5,
100 mM NaCl, 0.1 mM EDTA, 0.1 mM DTT) for the identifica-
tion experiments, and Tris buffer (20 mM Tris pH 7.5, 100–
300 mM NaCl, 0.1 mM DTT, 2 mM CaCl2) for the kinetics. The
flow rates were 10 ml/min and 30 ml/min respectively. Regenera-
tion of the chip was done with 10 ml 3 M NaCl in 100 mM NaOH.
BIAevaluation software version 4.1 was used to evaluate the results,
and 1:1 Langmuier model to fit the experimental results in order to
calculate the affinity and kinetics constants.
In vitro binding assay
Anion exchange fractions showing interaction activity in the
BIAcore analysis were pooled together (300 ml total volume) and
incubated in a 360u rotation shaker for 2 h at 4uC with 30 mlo f
Ni–NTA beads (Qiagen, Hilden, Germany) pre-bound to freshly-
extracted His-tagged GNE, as described (10). The beads were
washed three times with NaPi buffer (10 mM NaPi pH 7.5,
0.1 mM EDTA, 0.1 mM DTT, 100 mM NaCl), resuspended in
sample buffer (62.5 mM Tris pH 6.8, 10% glycerol, 5% b-ME,
3% SDS, BPB) and eluted by 59 incubation at 100uC. Eluted
samples were separated by 7–15% gradient SDS-PAGE and the
gel stained with GelCode blue stain reagent (Pierce, Rockford, IL,
USA), according to the manufacturer instructions. Protein bands
were cut from the gel for MS analysis.
Mass spectrometry analysis
Reduction, alkylation and trypsinization steps were carried out
in the gel as usual [17]. After extraction of the peptides from the
gel with 60% CH3CN 1% CHOOH solution, and evaporation to
dryness, the samples were rehydrated with 1 ml of CH3CN 1%
CHOOH solution, and then diluted with 9 ml of 1% CHOOH.
The peptide mixtures were either solid phase extracted with C18
resin filled tip (ZipTip; Milipore, Billerica, MA, USA) and
nanosprayed into the Qtof2 MS system in 50% CH3CN 1%
CHOOH solution, or injected to 0.75 ml C18 column on a
capillary HPLC system (CapLC; Waters, Milford, MA, USA)
coupled to the MS. MS/MS was carried out with Qtof2
(Micromass, Manchester, UK) using nanospray attachment [18].
Data analysis was done using the biolynx package V4.0
(Micromass), and database searches were performed with the
Mascot package (Matrix Science, London, UK). Precursor-ion
mass tolerance 1.2, fragment-ion mass tolerance 0.6, one missed
cleavage, modifications allowed: Carbamidomethyl (C), Oxidation
(M), Propionamide (C). Ions score is 210*Log(P), where P is the
probability that the observed match is a random event. Individual
ions scores .55 indicate identity or extensive homology (p,0.05).
Protein scores are derived from ions scores as a non-probabilistic
basis for ranking protein hits. The database searched was NCBInr
20060831 (3894824 sequences; 1340658132 residues). Five unique
peptides were identified matching several members of the a-
actinin family (actinin1, 2, 3, 4); nevertheless only one member of
the family, a-actinin 1, aligned to each of the five peptides with
100% identity.
LDH-B and a-actinin 1 recombinant proteins
Full length placental a-actinin 1 [19], cloned into the 6xHis
pET-15b vector (Novagen, Darmstadt, Germany), was a gift of Dr.
Bankston, the Burnham Institute, La Jolla, CA, USA. Transfor-
mation into BL21(DE3)pS
+ E. coli cells and purification of the
protein were performed as described [20]. Recombinant chicken
LDH-B protein was purchased from ProSpec-Tany TechnoGene
(Rehovot, Israel).
Overexpression of FLAG-GNE in 293T cells
The cDNA sequence of human GNE (NM_005476.3) was cloned
into N-terminal 3XFLAG-CMV-10 expression vector (SIGMA)
according to standard procedures and transfected into human
GNE Binds to Alpha Actinin 1
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Carlsbad, CA, USA) according to the manufacturer instructions.
Transfected cells were selected in growth medium (DME medium
containing 10% FCS, 584 mg/ml Glutamin, 20 U/ml penicillin,
20 mg/ml streptomycin) containing 400 mg/ml Geneticin (G-418;
Gibco, Paisley, UK) for 10 days. The selected stably-transfected
293T cells (293T-FG) were grown in selection medium. Expression
oftheFLAG-taggedGNEproteininthetransfectedcellswasverified
by Western blot analysis, as described below.
Co-Immunoprecipitation (co-IP)
FLAG-GNE transfected 293T cells (293T-FG) and untrans-
fected (UT) control cells were grown in 75 cm
2 flasks till sub-
confluency (,70%), crosslinked or not crosslinked with DSP
(Pierce) according to the manufacturer instructions, collected and
lysed as described above for muscle cells (without DTT and
EDTA). Lysates (900 mg of total protein) were first incubated with
50 ml mouse ExactaCruz C IP matrix (Santa Cruz Biotechnology,
Santa Cruz, CA, USA) for pre-clearing, for 309 at 4uC, and then
incubated overnight at 4uC in a 360u rotation shaker with anti-
FLAG M2 mouse monoclonal antibody (10 mg/ml, SIGMA) pre-
bound to 50 ml of mouse ExactaCruz C IP matrix. After washing
the beads twice by 59 rotation in PBS, immunoprecipitated
proteins were eluted in sample buffer containing b-ME, as
described above. As a control for successful crosslinking, 5 mgo f
lysate samples were dissolved in SDS-sample without b-ME.
Western blot analysis
For Western blotanalysis, lysatealiquotsandeluatesof co-IP were
separated by 7.5% SDS–PAGE and blotted according to standard
procedures. After overnight blocking in 5% BSA/PBS-Tween
(0.1%), membrane was incubated overnight at 4uCw i t hr a b b i t
polyclonal anti a-actinin (H-300) primary antibody (1:500; Santa
Cruz Biotechnology) in 5% BSA/PBS-Tween (0.1%). Detection was
performed with rabbit HRP-conjugated ExactaCruz C detection
reagent (1:1,000; Santa Cruz Biotechnology). FLAG-GNE was
detected on the same membrane using anti-FLAG M2 mouse
monoclonal primary antibody (SIGMA), and secondary HRP-
conjugated goat anti mouse antibody (Jackson ImmunoResearch,
West Grove, PA, USA). Protein expression was visualized using the
SuperSignal West Pico Chemiluminescent Substrate (Pierce).
Immunofluorescence staining of C2C12 cells
Mouse C2C12 myoblasts were cultured in 40% high-glucose
Dulbecco’s modified eagle medium and 40% F-12 Nutrient Mixture
(HAM)withL-glutamine, supplemented with 10% fetal bovine serum
and 10% horse serum. For differentiation, the cells were cultured in
48.5% high-glucose Dulbecco’s modified eagle medium and 48.5%
F-12 Nutrient Mixture (HAM) with L-glutamine, supplemented with
3% horse serum. C2C12 cells grown on Thermanox coverslips
(Nunc) were fixed and permeabilized in PBS containing 3%
paraformaldehyde and 0.1% triton X-100 for 20 minutes at room
temperature. Samples were washed in PBS three times, then blocked
with 2% BSA in PBS for 10 min and incubated for 1 h at room
temperature with a polyclonal antibody (pAb) a-actinin-1 (3A2;
1:100; Courtesy Prof Alan Beggs) [21]. After washing in PBS, cells
were incubated 309 at RT with the secondary antibody, Cy3-
conjugated goat anti-rabbit IgG (1:250; Jackson ImmunoResearch
Laboratories, West Grove, PA), diluted in 2% BSA/PBS.
Fixation and Immunostaining of Stretched Mouse Muscle
Freshly-harvested mouse spinalis muscle was lightly stretched in
the longitudinal direction by clamping the opposite ends of the
muscle onto a piece of cardboard (covered with aluminium foil).
The muscle was fixed in 3% paraformaldehyde for 10 minutes at
room temperature, covered in Tissue-tek and snap-frozen in liquid
nitrogen-cooled isopentane. The muscle was stored in liquid
nitrogen until required. Frozen muscle sections (5 mm) were
blocked in 2% bovine serum albumin (BSA) in phosphate-buffered
saline (PBS) for 10 minutes. After rinsing in PBS, sections were
incubated overnight at 4uC in primary antibody. Primary
antibodies were monoclonal antibody a-actinin-2 (1:400; Sigma,
St. Louis, MO), polyclonal antibody (pAb) a-actinin-1 (3A2; 1:100;
Courtesy Prof Alan Beggs) and polyclonal antibody GNE (1:100,
Courtesy Dr Sabine Krause) [22]. After washing in PBS, sections
were blocked as mentioned above and then incubated for 3 hours
at room temperature in secondary antibodies. Secondary antibod-
ies were Cy3-conjugated goat anti-mouse IgG (1:250; Jackson
ImmunoResearch Laboratories, West Grove, PA) and Alexa Fluor
488 goat anti-rabbit IgG (1:200; Molecular Probes, Eugene, OR).
Sections were washed by immersion in PBS for 30 min and
mounted on 22650 mm
2 glass coverslips using Fluorsave
mounting reagent (Calbiochem, SanDiego, CA).
Microscopic analysis
Confocal photographs were taken by Leica TCS SP2 Scanning
Confocal Microscope equipped with HCX Plan Apo (PH3) 406/
1.25 and 636/1.32 oil immersion objective lenses.. GelMount
(SIGMA) imaging medium was used. All pictures were taken at RT.
Results
Biacore analysis of muscle cell extract on GNE proteins
A freshly prepared lysate from human primary skeletal muscle
culture cells (15 mg total protein content) was fractionated by
anion-exchange chromatography to produce 26 fractions
(Figure 1A). Interaction between GNE and the different fractions
was tested using SPR technology. Freshly prepared normal and
mutant (M712T) GNE proteins were immobilized on a CM5 chip
using an amine coupling protocol. 50 ml of each of the fractions
were injected over the immobilized chip. Binding signals were
obtained, in fractions #12–16 which were eluted in 340–620 mM
NaCl (Figure 1B). Similar results were obtained with the mutant
GNE protein. Two pools of positive fractions (#11–13 and #14–
16) were further analyzed by in vitro binding assay.
In vitro binding assay
In order to recognize the relevant proteins within the skeletal
muscle lysate fractions which gave a positive GNE-binding signal,
the pooled fractions (#11–13 and #14–16) were incubated with
GNE-bound nickel beads. Two negative controls were used: Ni-
NTA beads which were not bound to GNE were incubated with
the same fractions, and GNE-bound Ni-NTA beads were
incubated with lysis buffer. Bound proteins were eluted from the
beads, resolved by a gradient SDS-PAGE and visualized by
Gelcode reagent staining (Figure 2). The candidate bands, as well
as the corresponding gel-areas or bands of the negative-controls,
were cut from the gel for analysis by MS. Among all MS-identified
proteins, only two were not found in negative controls. Those two
proteins were identified as a-actinin 1 (103 kDa) and lactate
dehydrogenase B (LDH-B) (36 kDa) (Table 1).
Biacore analysis with GNE and a-actinin 1
The putative interaction between GNE and a-actinin 1 was tested
directly using BIAcore. 15 mlo f5mM a-actinin 1, diluted in Tris
buffer containing 300 mM NaCl, were injected over immobilized
GNE. Specific binding signals were obtained with both WT and
GNE Binds to Alpha Actinin 1
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in order to determine their affinity and kinetics constants, and
whether any differences in the affinity binding between WT and
mutant GNE proteins could be detected. The results are shown on
Figure3andTable2.Noconsistentdifferencewasobtainedbetween
the interactions of a-actinin 1 with WT compared to mutant GNE,
in four independent assays. As a control for GNE-a-actinin 1
interaction specificity, 1–10 mM BSA were injected, and no
interaction was detected. Since a-actinin 1 is calcium-sensitive
[23], we analyzed the effect of CaCl2 on the interaction affinity
between GNE and a-actinin 1, by replacing the 2 mM CaCl2 by
2 mM EDTA in the Tris buffer. Excluding CaCl2 decreased the
affinity of both WT and mutant GNE to a-actinin 1 by ten fold (for
WT, 6.8610
28 Ma n d2 . 5 6 610
27 M, with and without CaCl2,
respectively; for mutant, 4.5610
28 M and 3.9610
27 M, with and
without CaCl2, respectively). The same result was obtained in two
independent analyses, indicating that although this interaction is
calcium independent in principle, calcium has a significant positive
effect on it.
Biacore analysis with GNE and LDH-B
The putative interaction between GNE and LDH-B was tested as
well. Various concentrations of LDH-B (1–27 mM) were injected in
different buffers (Tris HEPES, PBS or NaPi), but no interaction was
detected. Figure 4A shows the results obtained for a-actinin 1-GNE
versusLDH-B-GNEinteractionswhentestedatthesameconditions:
a binding signal was obtained with a-actinin 1, but not with LDH-B.
As shown in Figure 4B, 2 mM LDH-B did not have any effect on the
binding of 0.5 mM actinin to GNE, excluding the hypothesis that
LDH-B may act as a co-factor for GNE-a-actinin 1 interaction.
Therefore a direct interaction between GNE and LDH-B could not
be demonstrated in vitro by BIAcore analysis.
Co-Immunoprecipitation (co-IP) of FLAG-GNE and a-
actinin
To verify whether the interaction between GNE and a-actinin
takes place also in a cellular environment, we performed co-
immunoprecipitation experiments using human 293T cells,
overexpressing the FLAG-GNE protein (293T-FG, or shortly T).
As a negative control, we used untransfected 293T cells (UT)
(Figure 5). a-Actinin is highly expressed in both cell types
(Figure 5). By immunoprecipitation of cell protein lysates with
anti-FLAG antibody bound beads, a-actinin was not detected with
FLAG-GNE (data not shown). To test the possibility that the
interaction is disrupted during the cell lysing process, proteins were
crosslinked with DSP within the intact cells prior to their
extraction. This crosslinker is membrane permeable, and can be
cleaved by boiling the protein samples in 5% b-ME containing
SDS-sample buffer. The effect of DSP crosslinking on both
proteins was verified by western blot analyses with anti-FLAG and
anti a-actinin antibodies (Figure 5A). Cell lysates (5 mg) were
diluted in SDS-sample buffer, with or without 5% b-ME. In the
absence of b-ME, the signal of both proteins was detected at the
upper region of the SDS-PAGE gel, equivalent to MW of 250 kDa
or higher, while b-ME treatment resolved the crosslinking and
resulted in two distinct signals corresponding to the molecular
weights of FLAG-GNE (75 kDa) (Figure 5A-1) and a-actinin
(100 kDa) (Figure 5A-2). After immunoprecipitation with the anti-
FLAG bound beads, the eluted protein samples were analyzed by
western blot with anti-a-actinin and anti-FLAG antibodies. As
Figure 1. WT-GNE interacts with proteins within anion-exchanged fractions of muscle cell lysate. [A] Anion exchange chromatography
(0–1 M NaCl) of cell lysate (15 mg total protein content) extracted from human skeletal muscle primary culture cells. The numbers of the positive
fractions appear in red on the X axis. [B] BIAcore sensorgrams of the interaction of WT-GNE with anion exchange fractions #11–16 [Resp. Diff.,
response difference; RU, response units; B, buffer B (see Materials and methods)].
doi:10.1371/journal.pone.0002477.g001
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detected only in the sample originating from 293T-FG cells, but
not in UT control cells. Our results demonstrate that a actinin
coimmunoprecipitates with FLAG-GNE in 293T-FG cells.
Localization of GNE and a-Actinin 1 in muscle tissue
a-Actinin 1 is generally regarded as one of the non-muscle
isoforms of a-actinin family. To confirm that it is expressed in
muscle cells rather than in non-muscle structures within muscles
(such as blood vessels), we examined its expression in a mouse
myoblast line (C2C12 cells). Indeed, a-actinin 1 antibody stained
undifferentiated and differentiated myoblasts (Figure 6). To assess
the expression of GNE and a-actinin 1 in mature muscle, we co-
stained each of the polyclonal antibodies anti a-actinin 1 and anti
GNE with an antibody to the muscle Z line marker sarcomeric
actinin (a-actinin 2) in mouse stretched spinalis muscle (Figure 7).
Both a-actinin1 (Figure 7A) and GNE (Figure 7B) antibodies
recognized an overlapping but not fully superimposed striated
pattern: antibodies to both proteins stained around or close to the
muscle Z line, as well as a fainter staining at the sarcomeric M line.
However the localization around the Z line differed between the 2
proteins in stretched muscle, with GNE forming a diffuse band
centered on the Z line, while a-actinin 1 is found as two distinct
bands on either side of the Z line, suggesting that GNE and a-
actinin 1 are expressed in distinct but overlapping compartments
in skeletal muscle.
Discussion
The GNE gene is mutated in all HIBM patients [3], but the role
of the altered GNE protein leading to the disease phenotype is not
yet understood. The aim of our study was to search for potential
GNE protein interactors which could unravel novel functions of
GNE, possibly not related to its well known role in the biosynthesis
of sialic acids. Since previous traditional co-immunoprecipitation
assays for identification of GNE protein partners did not yield any
positive results, we used BIAcore, an optical SPR-bio sensor
(Surface Plasmon Resonance) system, to test GNE’s interactions.
BIAcore is generally used for kinetic characterization of a known
interaction between two biomolecules. Since we had no clue about
the identity of the potential GNE binding proteins in muscle cells,
we applied the BIAcore system as a bioassay similar to the one
described by Catimel et al. [24], who immobilized proteins onto
Figure 2. LDH-B and a-actinin 1 precipitate with GNE by in vitro
binding assay. Gelcode reagent staining of in vitro binding assay
eluates resolved by SDS-PAGE. Numbers (11–13, 14–16) correspond to
anion-exchange pooled fractions. A, proteins bound to GNE-bound
nickel beads; B, proteins bound to GNE non-bound nickel beads; C,
control proteins bound to GNE-bound nickel beads. Black arrows point
to either a-actinin 1 (,100 kDa) or to LDH-B (,37 kDa). Both proteins
were identified by MS (Table 1).
doi:10.1371/journal.pone.0002477.g002
Table 1. MS identification of putative GNE binding partners.
Protein
MW
kDa
Accession
number
Sequence
coverage (aa)
Matched
peptides Peptides sequences
Observed
precursor
m/z z Mr (expt.) Mr (calc.)
Delta
mass
(amu) Score
LDHB 36 gi|213255 12/334 (3.5%) 1/35 VIGSGTNLDSAR 595.2839 2 1188.5533 1188.6098 20.0565 64
alpha actinin 1 103 gi|4501891 63/892 (7%) 5/103 LMLLLEVISGER 686.3339 2 1370.6533 1371.7795 21.1262 97
LVSIGAEEIVDGNVK 771.5139 2 1541.0133 1541.83 20.8167
LASDLLEWIR 608.3039 2 1214.5933 1214.6659 20.0726
LLETIDQLYLEYAK 856.4239 2 1710.8333 1710.908 20.0747
VGWEQLLTTIAR 693.3639 2 1384.7133 1385.7667 21.0534
Bands from gradient SDS-PAGE (Figure 2) were digested by trypsin and analyzed by mass spectrometry through nano-ESI-MS-MS. For each protein, the following
information is indicated: protein name, molecular mass (MW), accession number in NCBInr database, percentage of protein sequence covered by the matched and
sequenced tryptic fragments, number of identified peptides out of the total number of tryptic peptides, peptides sequences, mass difference between experimental
and theoretical masses, and score (aa, amino acids; expt., expected; calc., calculated).
doi:10.1371/journal.pone.0002477.t001
Table 2. Kinetics BIAcore analysis for the interaction of GNE
with a-actinin 1.
Ka (1/Ms) Kd (1/s) KD (M) Chi
2
WT-GNE 1.82610
4 1.24610
23 6.8610
28 0.619
Mutant-GNE 1.23610
4 1.01610
23 8.2610
28 1.58
Kinetics values of the interactions of WT and mutant GNE proteins with a-
actinin 1 as calculated using 1:1 Langmuir model.
doi:10.1371/journal.pone.0002477.t002
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with different a-actinin 1 concentrations and the residual curves, showing the fitness between the model and the experimental results [Resp. Diff.,
response difference; RU, response units].
doi:10.1371/journal.pone.0002477.g003
Figure 4. LDH-B does not show BIAcore binding signal with GNE. [A] Sensorgram of the interaction of GNE with 5 mM LDH-B, compared to
5 mM a-actinin 1. [B] Sensorgram showing the effect of 2 mM LDH-B on the interaction of GNE with 0.5 mM a-actinin 1 [Resp. Diff., response difference;
RU, response units].
doi:10.1371/journal.pone.0002477.g004
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chromatographically enriched cell lysates. We immobilized WT
and mutant (M712T) GNE proteins to the BIAcore sensor chip,
and run through it anion exchanged fractions of human skeletal
muscle primary culture cell lysate. Analysis of fractions showing
binding signal by in vitro binding assay revealed two potential
protein partners of GNE, LDH-B and a-actinin 1. While a direct
interaction of GNE with LDH-B could not be shown by kinetics
BIAcore analysis, this assay clearly illustrated the binding between
GNE and a-actinin 1. Further, we showed by a co-IP assay that
GNE and a-actinin interact in a cellular environment, and by
immunohistochemistry, that GNE and a-actinin 1 are expressed in
distinct but overlapping compartments in skeletal muscle.
a-Actinin 1 is one of the four family members of a-actinins (1–
4), which belong to the spectrin protein superfamily including the
spectrins and dystrophin [25]. a-Actinin is an actin binding and
crosslinking protein, a homodimer with 100 kDa subunits which
can be visualized as a long rod-shaped molecule by electron
microscopy [23]. The a-actinins are known to be present in
multiple subcellular compartments, including cell–cell and cell-
matrix contact sites, cellular protrusions and stress fiber dense
regions [26]. One of the protein isoforms, a-actinin 4, was found
to be localized also to the nucleus in various cancer cell lines
[27,28], as well as in a differentiated skeletal muscle cell line [29].
GNE is an enzyme primarily localized in the cytosol (8). However,
it was shown to be attached to the Golgi complex and in the
nucleus of mammalian cells as well [22].
Binding of calcium to the non-muscle a-actinins (1 and 4)
changes the conformation of the protein and inhibits its actin
binding capacity [30]. In contrast, muscle a-actinins (2 and 3) are
calcium insensitive since alternative splicing abolished their
calcium binding ability [25]. Interestingly, we found that calcium
has a significant positive effect on a-actinin 1 interaction with
GNE. Further analysis is needed in order to recognize the precise
Figure 5. a-Actinin is co-immunoprecipitated with FLAG-GNE in 293T-FG cells. [A] Western blot analyses with anti-FLAG antibody (A1) and
anti-a-actinin antibody (A2) on 5 mg lysate-samples of FLAG-GNE (FG)-transfected (T) and untransfected (UT) 293T cells, treated with SDS sample
buffer in the presence (+) or absence (2)o fb-ME. [B] Co-IP results. Western blot analyses with anti-FLAG antibody and anti-a-actinin antibody of IP
eluates and 5 mg lysate-samples, of FLAG-GNE (FG)-transfected (T) and untransfected (UT) 293T cells.
doi:10.1371/journal.pone.0002477.g005
Figure 6. a-Actinin 1 is expressed in skeletal muscle. Light microscopy of mouse muscle culture (C2C12) at differentiation day (DD) 0 (1), DD 1
(2) and DD 3 (3) stained with antibody to a-actinin-1 (3A2).
doi:10.1371/journal.pone.0002477.g006
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the conformational change caused by calcium binding improves
this interaction.
The a-actinins contribute to both the stability and the plasticity of
actin-based arrays [26]. In addition to their function as actin-
crosslinking proteins, a-actinins have been found to interact with a
large number of protein partners, and to play multiple roles in cells,
including linking of the cytoskeleton to various transmembrane
proteins, diverse signaling pathways, and regulating the activity of a
variety of receptors [26]. In light of recent reports on the interaction
in nerve cells between GNE and a brain specific protein involved in
the modulation of the cytoskeleton, CRMP1 [31], and on the
possible involvement of GNE in pAkt signaling pathways [16], the
interaction of GNE with a-actinin 1 could point to the involvement
of GNE in one or more of these processes.
Although the interaction of HIBM mutant GNE with a-actinin
1, as measured by BIAcore, could not be significantly distinguished
from that of the wild-type protein, we cannot rule out the
possibility that any micro-change in this interaction might
contribute to HIBM pathophysiology. It might be that in vivo the
mutant GNE binds to a-actinin 1 in a slightly different manner or
affinity, and therefore the effect of this change is not seen in
normal biological conditions, but it has a deleterious effect on
HIBM cells upon long term stress conditions. Since the BIAcore in
vitro assay cannot mimic in vivo stress conditions, further
experiments in cellular environments, designed to test the
differences between the interactions of mutant and WT GNEs
with a-actinins, are needed in order to test this hypothesis.
Another possibility of how the BIAcore in vitro conditions may
conceal a difference between GNE wt and GNE M712T in actinin
interaction may derive from the different oligomeric forms of the
enzyme. GNE assembles in two oligomeric states, a tetramer with
full enzymatic activity and a dimmer only possessing ManNAc
kinase activity [32]. The relatively rough conditions for immobi-
lization of recombinant GNE on the BIAcore chip most likely
cause the decay of the tetramer and only dimmers are available in
the interaction assay. A difference of tetrameric wt versus mutant
GNE in actinin interaction can therefore not be excluded and
should be analyzed by other methods, e.g. pull-down assays with
pre-purified tetrameric or dimeric GNE. However, the possibility
that tetrameric GNE cannot interact with actinin at all can be
ruled out, as the conditions of the co-immunoprecipitation assay
maintain the native, tetrameric state of the enzyme in cells.
In contrast to the sarcomeric isoforms of a-actinin (2 and 3),
which are components of the sarcomeric Z disc where they
crosslink actin filaments and stabilize the muscle contractile
apparatus [25], a-actinin 1 and 4 are considered as the non-muscle
isoforms of the protein. Therefore, we were surprised to find the
GNE interactor expressed in skeletal muscle primary culture to be
a-actinin 1. Interestingly, this is not the first evidence for the
expression of non-muscle a-actinins in a myogenic cell line. Endo
and Masaki [33] found that both skeletal and smooth muscle
actinins are expressed in cultured embryonic chicken pectoralis
cells. The two proteins were found at separate locations within the
cells; skeletal muscle a-actinin was absent in myoblasts and was
restricted to Z discs in myotubes. Smooth muscle a-actinin was
diffused in the cytoplasm and on membrane-associated structures
of myoblasts, and then confined to membrane-associated struc-
tures of myotubes. In contrast, Goffart et al. reported recently [29]
that both a-actinin 1 and 4 are expressed in C2F3 cells, a subclone
of the myogenic mouse C2C12 line. The two proteins were found
to be expressed in both myoblasts and myotubes. a-Actinin 1 was
Figure 7. GNE and a-actinin 1 are expressed in stretched mouse muscle. Confocal microscopy of stretched mouse spinalis muscle stained
with antibodies recognizing the Z line marker a-actinin-2 (ACTN2, red), a-actinin-1 (ACTN1, green), and GNE (GNE, green). a-Actinin-1 antibodies(3A2)
and GNE antibodies show a distinct but overlapping staining pattern: GNE Abs recognize a diffuse band centered on the Z line while a-actinin-1 Abs
stain two distinct bands on either side of the Z line. Both Abs recognize also, as a fainter staining, the sarcomeric M line. Overlap stain between a-
actinin-1 and a-actinin-2 Abs is minimal.
doi:10.1371/journal.pone.0002477.g007
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localized to both cytoplasm and nucleus of myoblasts, and mainly
to the nucleus of myotubes. In the present study we have
confirmed that a-actinin 1 is expressed in C2C12 muscle cultures,
excluding the possibility that expression of a-actinin-1 in skeletal
muscle is limited to smooth muscle structures such as blood vessels.
To assess the relevance of our findings in mature muscle tissue, we
examined the expression of a-actinin 1 and GNE in mouse
stretched spinalis muscle. While the localization of the two proteins
is distinct, a substantial degree of overlap provides preliminary
evidence that the interaction observed in vitro may plausibly occur
in vivo in mouse skeletal muscle. Further comprehensive investi-
gation is needed to elucidate the precise localization of a-actinin 1
and GNE in the myofibrillar apparatus centered on the Z line, and
the relevance of a-actinin 1 function in skeletal muscle to its
interaction with GNE in general, and to HIBM pathophysiology
in particular.
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